The global market for Genomic and Proteomic Tool was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Smart food logistics provider helps FMCG industries to maintain the quality of foods, such as fruits and vegetables, so that it does not spoil. Smart food logistics companies use wireless temperature sensors that help preserve frozen foods and provide multi-zone monitoring in refrigerated trucks and trailers.

North American market for Genomic and Proteomic Tool is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Genomic and Proteomic Tool is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Genomic and Proteomic Tool in Research Labs and Institutes is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Genomic and Proteomic Tool include 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare, QIAGEN NV, Novogene Corp., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Genomic and Proteomic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic and Proteomic Tool.

The Genomic and Proteomic Tool market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genomic and Proteomic Tool market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Genomic and Proteomic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Genomic and Proteomic Tool Market Report

Report Metric	Details
Report Name	Genomic and Proteomic Tool Market
Segment by Type	Genomics Proteomics
Segment by Application	Research Labs and Institutes Drug Discovery Bioinformatics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare, QIAGEN NV, Novogene Corp., Waters Corp., OriGene Technologies, Takara Bio, Inc., Vela Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic and Proteomic Tool company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Genomic and Proteomic Tool Market report?

Ans: The main players in the Genomic and Proteomic Tool Market are 3billion, Inc., Bio-Rad Laboratories, Inc., Lucigen Corp., Macrogen, Inc., Abbott, Thermal Fisher Scientific, Inc., Bio-Synthesis, Inc., GE Healthcare, QIAGEN NV, Novogene Corp., Waters Corp., OriGene Technologies, Takara Bio, Inc., Vela Diagnostics

What are the Application segmentation covered in the Genomic and Proteomic Tool Market report?

Ans: The Applications covered in the Genomic and Proteomic Tool Market report are Research Labs and Institutes, Drug Discovery, Bioinformatics, Others

What are the Type segmentation covered in the Genomic and Proteomic Tool Market report?

Ans: The Types covered in the Genomic and Proteomic Tool Market report are Genomics, Proteomics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Genomic and Proteomic Tool Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Genomics

1.2.3 Proteomics

1.3 Market by Application

1.3.1 Global Genomic and Proteomic Tool Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Research Labs and Institutes

1.3.3 Drug Discovery

1.3.4 Bioinformatics

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Genomic and Proteomic Tool Market Perspective (2020-2031)

2.2 Global Genomic and Proteomic Tool Growth Trends by Region

2.2.1 Global Genomic and Proteomic Tool Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Genomic and Proteomic Tool Historic Market Size by Region (2020-2025)

2.2.3 Genomic and Proteomic Tool Forecasted Market Size by Region (2026-2031)

2.3 Genomic and Proteomic Tool Market Dynamics

2.3.1 Genomic and Proteomic Tool Industry Trends

2.3.2 Genomic and Proteomic Tool Market Drivers

2.3.3 Genomic and Proteomic Tool Market Challenges

2.3.4 Genomic and Proteomic Tool Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Genomic and Proteomic Tool Players by Revenue

3.1.1 Global Top Genomic and Proteomic Tool Players by Revenue (2020-2025)

3.1.2 Global Genomic and Proteomic Tool Revenue Market Share by Players (2020-2025)

3.2 Global Genomic and Proteomic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Genomic and Proteomic Tool Revenue

3.4 Global Genomic and Proteomic Tool Market Concentration Ratio

3.4.1 Global Genomic and Proteomic Tool Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Genomic and Proteomic Tool Revenue in 2024

3.5 Global Key Players of Genomic and Proteomic Tool Head office and Area Served

3.6 Global Key Players of Genomic and Proteomic Tool, Product and Application

3.7 Global Key Players of Genomic and Proteomic Tool, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Genomic and Proteomic Tool Breakdown Data by Type

4.1 Global Genomic and Proteomic Tool Historic Market Size by Type (2020-2025)

4.2 Global Genomic and Proteomic Tool Forecasted Market Size by Type (2026-2031)

5 Genomic and Proteomic Tool Breakdown Data by Application

5.1 Global Genomic and Proteomic Tool Historic Market Size by Application (2020-2025)

5.2 Global Genomic and Proteomic Tool Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Genomic and Proteomic Tool Market Size (2020-2031)

6.2 North America Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Genomic and Proteomic Tool Market Size by Country (2020-2025)

6.4 North America Genomic and Proteomic Tool Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Genomic and Proteomic Tool Market Size (2020-2031)

7.2 Europe Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Genomic and Proteomic Tool Market Size by Country (2020-2025)

7.4 Europe Genomic and Proteomic Tool Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Genomic and Proteomic Tool Market Size (2020-2031)

8.2 Asia-Pacific Genomic and Proteomic Tool Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2020-2025)

8.4 Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Genomic and Proteomic Tool Market Size (2020-2031)

9.2 Latin America Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Genomic and Proteomic Tool Market Size by Country (2020-2025)

9.4 Latin America Genomic and Proteomic Tool Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Genomic and Proteomic Tool Market Size (2020-2031)

10.2 Middle East & Africa Genomic and Proteomic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2020-2025)

10.4 Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 3billion, Inc.

11.1.1 3billion, Inc. Company Details

11.1.2 3billion, Inc. Business Overview

11.1.3 3billion, Inc. Genomic and Proteomic Tool Introduction

11.1.4 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.1.5 3billion, Inc. Recent Development

11.2 Bio-Rad Laboratories, Inc.

11.2.1 Bio-Rad Laboratories, Inc. Company Details

11.2.2 Bio-Rad Laboratories, Inc. Business Overview

11.2.3 Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Introduction

11.2.4 Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.2.5 Bio-Rad Laboratories, Inc. Recent Development

11.3 Lucigen Corp.

11.3.1 Lucigen Corp. Company Details

11.3.2 Lucigen Corp. Business Overview

11.3.3 Lucigen Corp. Genomic and Proteomic Tool Introduction

11.3.4 Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.3.5 Lucigen Corp. Recent Development

11.4 Macrogen, Inc.

11.4.1 Macrogen, Inc. Company Details

11.4.2 Macrogen, Inc. Business Overview

11.4.3 Macrogen, Inc. Genomic and Proteomic Tool Introduction

11.4.4 Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.4.5 Macrogen, Inc. Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Genomic and Proteomic Tool Introduction

11.5.4 Abbott Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.5.5 Abbott Recent Development

11.6 Thermal Fisher Scientific, Inc.

11.6.1 Thermal Fisher Scientific, Inc. Company Details

11.6.2 Thermal Fisher Scientific, Inc. Business Overview

11.6.3 Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Introduction

11.6.4 Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.6.5 Thermal Fisher Scientific, Inc. Recent Development

11.7 Bio-Synthesis, Inc.

11.7.1 Bio-Synthesis, Inc. Company Details

11.7.2 Bio-Synthesis, Inc. Business Overview

11.7.3 Bio-Synthesis, Inc. Genomic and Proteomic Tool Introduction

11.7.4 Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.7.5 Bio-Synthesis, Inc. Recent Development

11.8 GE Healthcare

11.8.1 GE Healthcare Company Details

11.8.2 GE Healthcare Business Overview

11.8.3 GE Healthcare Genomic and Proteomic Tool Introduction

11.8.4 GE Healthcare Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.8.5 GE Healthcare Recent Development

11.9 QIAGEN NV

11.9.1 QIAGEN NV Company Details

11.9.2 QIAGEN NV Business Overview

11.9.3 QIAGEN NV Genomic and Proteomic Tool Introduction

11.9.4 QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.9.5 QIAGEN NV Recent Development

11.10 Novogene Corp.

11.10.1 Novogene Corp. Company Details

11.10.2 Novogene Corp. Business Overview

11.10.3 Novogene Corp. Genomic and Proteomic Tool Introduction

11.10.4 Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.10.5 Novogene Corp. Recent Development

11.11 Waters Corp.

11.11.1 Waters Corp. Company Details

11.11.2 Waters Corp. Business Overview

11.11.3 Waters Corp. Genomic and Proteomic Tool Introduction

11.11.4 Waters Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.11.5 Waters Corp. Recent Development

11.12 OriGene Technologies

11.12.1 OriGene Technologies Company Details

11.12.2 OriGene Technologies Business Overview

11.12.3 OriGene Technologies Genomic and Proteomic Tool Introduction

11.12.4 OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.12.5 OriGene Technologies Recent Development

11.13 Takara Bio, Inc.

11.13.1 Takara Bio, Inc. Company Details

11.13.2 Takara Bio, Inc. Business Overview

11.13.3 Takara Bio, Inc. Genomic and Proteomic Tool Introduction

11.13.4 Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.13.5 Takara Bio, Inc. Recent Development

11.14 Vela Diagnostics

11.14.1 Vela Diagnostics Company Details

11.14.2 Vela Diagnostics Business Overview

11.14.3 Vela Diagnostics Genomic and Proteomic Tool Introduction

11.14.4 Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2020-2025)

11.14.5 Vela Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

3Billion Inc.

Bio-Rad Laboratories Inc

Lucigen Corp.

Macrogen

Abbott

Thermal Fisher Scientific Inc.

List of Tables

Table 1. Global Genomic and Proteomic Tool Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Genomics

Table 3. Key Players of Proteomics

Table 4. Global Genomic and Proteomic Tool Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Genomic and Proteomic Tool Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Genomic and Proteomic Tool Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Genomic and Proteomic Tool Market Share by Region (2020-2025)

Table 8. Global Genomic and Proteomic Tool Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Genomic and Proteomic Tool Market Share by Region (2026-2031)

Table 10. Genomic and Proteomic Tool Market Trends

Table 11. Genomic and Proteomic Tool Market Drivers

Table 12. Genomic and Proteomic Tool Market Challenges

Table 13. Genomic and Proteomic Tool Market Restraints

Table 14. Global Genomic and Proteomic Tool Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Genomic and Proteomic Tool Market Share by Players (2020-2025)

Table 16. Global Top Genomic and Proteomic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2024)

Table 17. Ranking of Global Top Genomic and Proteomic Tool Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Genomic and Proteomic Tool Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Genomic and Proteomic Tool, Headquarters and Area Served

Table 20. Global Key Players of Genomic and Proteomic Tool, Product and Application

Table 21. Global Key Players of Genomic and Proteomic Tool, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Genomic and Proteomic Tool Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Genomic and Proteomic Tool Revenue Market Share by Type (2020-2025)

Table 25. Global Genomic and Proteomic Tool Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Genomic and Proteomic Tool Revenue Market Share by Type (2026-2031)

Table 27. Global Genomic and Proteomic Tool Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Genomic and Proteomic Tool Revenue Market Share by Application (2020-2025)

Table 29. Global Genomic and Proteomic Tool Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Genomic and Proteomic Tool Revenue Market Share by Application (2026-2031)

Table 31. North America Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Genomic and Proteomic Tool Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Genomic and Proteomic Tool Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Genomic and Proteomic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Genomic and Proteomic Tool Market Size by Country (2026-2031) & (US$ Million)

Table 46. 3billion, Inc. Company Details

Table 47. 3billion, Inc. Business Overview

Table 48. 3billion, Inc. Genomic and Proteomic Tool Product

Table 49. 3billion, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 50. 3billion, Inc. Recent Development

Table 51. Bio-Rad Laboratories, Inc. Company Details

Table 52. Bio-Rad Laboratories, Inc. Business Overview

Table 53. Bio-Rad Laboratories, Inc. Genomic and Proteomic Tool Product

Table 54. Bio-Rad Laboratories, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 55. Bio-Rad Laboratories, Inc. Recent Development

Table 56. Lucigen Corp. Company Details

Table 57. Lucigen Corp. Business Overview

Table 58. Lucigen Corp. Genomic and Proteomic Tool Product

Table 59. Lucigen Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 60. Lucigen Corp. Recent Development

Table 61. Macrogen, Inc. Company Details

Table 62. Macrogen, Inc. Business Overview

Table 63. Macrogen, Inc. Genomic and Proteomic Tool Product

Table 64. Macrogen, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 65. Macrogen, Inc. Recent Development

Table 66. Abbott Company Details

Table 67. Abbott Business Overview

Table 68. Abbott Genomic and Proteomic Tool Product

Table 69. Abbott Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 70. Abbott Recent Development

Table 71. Thermal Fisher Scientific, Inc. Company Details

Table 72. Thermal Fisher Scientific, Inc. Business Overview

Table 73. Thermal Fisher Scientific, Inc. Genomic and Proteomic Tool Product

Table 74. Thermal Fisher Scientific, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 75. Thermal Fisher Scientific, Inc. Recent Development

Table 76. Bio-Synthesis, Inc. Company Details

Table 77. Bio-Synthesis, Inc. Business Overview

Table 78. Bio-Synthesis, Inc. Genomic and Proteomic Tool Product

Table 79. Bio-Synthesis, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 80. Bio-Synthesis, Inc. Recent Development

Table 81. GE Healthcare Company Details

Table 82. GE Healthcare Business Overview

Table 83. GE Healthcare Genomic and Proteomic Tool Product

Table 84. GE Healthcare Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 85. GE Healthcare Recent Development

Table 86. QIAGEN NV Company Details

Table 87. QIAGEN NV Business Overview

Table 88. QIAGEN NV Genomic and Proteomic Tool Product

Table 89. QIAGEN NV Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 90. QIAGEN NV Recent Development

Table 91. Novogene Corp. Company Details

Table 92. Novogene Corp. Business Overview

Table 93. Novogene Corp. Genomic and Proteomic Tool Product

Table 94. Novogene Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 95. Novogene Corp. Recent Development

Table 96. Waters Corp. Company Details

Table 97. Waters Corp. Business Overview

Table 98. Waters Corp. Genomic and Proteomic Tool Product

Table 99. Waters Corp. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 100. Waters Corp. Recent Development

Table 101. OriGene Technologies Company Details

Table 102. OriGene Technologies Business Overview

Table 103. OriGene Technologies Genomic and Proteomic Tool Product

Table 104. OriGene Technologies Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 105. OriGene Technologies Recent Development

Table 106. Takara Bio, Inc. Company Details

Table 107. Takara Bio, Inc. Business Overview

Table 108. Takara Bio, Inc. Genomic and Proteomic Tool Product

Table 109. Takara Bio, Inc. Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 110. Takara Bio, Inc. Recent Development

Table 111. Vela Diagnostics Company Details

Table 112. Vela Diagnostics Business Overview

Table 113. Vela Diagnostics Genomic and Proteomic Tool Product

Table 114. Vela Diagnostics Revenue in Genomic and Proteomic Tool Business (2020-2025) & (US$ Million)

Table 115. Vela Diagnostics Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Genomic and Proteomic Tool Picture

Figure 2. Global Genomic and Proteomic Tool Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Genomic and Proteomic Tool Market Share by Type: 2024 VS 2031

Figure 4. Genomics Features

Figure 5. Proteomics Features

Figure 6. Global Genomic and Proteomic Tool Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Genomic and Proteomic Tool Market Share by Application: 2024 VS 2031

Figure 8. Research Labs and Institutes Case Studies

Figure 9. Drug Discovery Case Studies

Figure 10. Bioinformatics Case Studies

Figure 11. Others Case Studies

Figure 12. Genomic and Proteomic Tool Report Years Considered

Figure 13. Global Genomic and Proteomic Tool Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Genomic and Proteomic Tool Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Genomic and Proteomic Tool Market Share by Region: 2024 VS 2031

Figure 16. Global Genomic and Proteomic Tool Market Share by Players in 2024

Figure 17. Global Top Genomic and Proteomic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic and Proteomic Tool as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Genomic and Proteomic Tool Revenue in 2024

Figure 19. North America Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Genomic and Proteomic Tool Market Share by Country (2020-2031)

Figure 21. United States Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Genomic and Proteomic Tool Market Share by Country (2020-2031)

Figure 25. Germany Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Genomic and Proteomic Tool Market Share by Region (2020-2031)

Figure 33. China Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Genomic and Proteomic Tool Market Share by Country (2020-2031)

Figure 41. Mexico Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Genomic and Proteomic Tool Market Share by Country (2020-2031)

Figure 45. Turkey Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Genomic and Proteomic Tool Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. 3billion, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 50. Lucigen Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 51. Macrogen, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 52. Abbott Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 53. Thermal Fisher Scientific, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 54. Bio-Synthesis, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 55. GE Healthcare Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 56. QIAGEN NV Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 57. Novogene Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 58. Waters Corp. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 59. OriGene Technologies Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 60. Takara Bio, Inc. Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 61. Vela Diagnostics Revenue Growth Rate in Genomic and Proteomic Tool Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Automatic Dosing Device Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8S20198

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Optically Clear PCR Strip Tubes Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-1L20132

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Avena Sativa Kernel Meal Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28Q19902

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions